Tine Schytte

Medicin og biovidenskab

1. Non-Small Cell Lung Carcinoma 100%
2. Radiotherapy 87%
3. Survival 38%
4. Magnetic Resonance Spectroscopy 30%
5. Lung 26%
6. Radiation 19%
7. Radiosurgery 18%
8. Neoplasms 17%
9. Patient Reported Outcome Measures 16%
10. Tomography 15%
11. Small Cell Lung Carcinoma 15%
12. Lung Neoplasms 15%
13. Neoplasm Metastasis 14%
14. Therapeutics 13%
15. Denmark 13%
16. Cone-Beam Computed Tomography 12%
17. Immunotherapy 12%
18. Thorax 11%
19. Chemoradiotherapy 11%
20. Workflow 11%
21. Lymph Nodes 10%
22. Drug Therapy 10%
23. Venous Thromboembolism 10%
24. Organs at Risk 9%
25. Prostatic Neoplasms 8%
26. Quality of Life 8%
27. Heart 8%
28. Positron Emission Tomography Computed Tomography 8%
29. Radiation Pneumonitis 8%
30. Survival Rate 7%
31. Cranial Irradiation 7%
32. Magnetic Resonance Imaging 7%
33. Intensity-Modulated Radiotherapy 7%
34. Registries 7%
35. Vinorelbine 6%
36. Adrenal Glands 6%
37. Geriatric Assessment 6%
38. Particle Accelerators 6%
39. Randomized Controlled Trials 6%
40. Coronary Vessels 6%
41. Liquid Biopsy 6%
42. Retrospective Studies 6%
43. Comorbidity 6%
44. Brain 6%
45. University Hospitals 6%
46. Pemetrexed 6%
47. Lung Injury 6%
48. Safety 6%
49. Esophagitis 5%
50. Cryosurgery 5%